R-Tech Ueno has begun enrolling patients with severe dry eye in Phase I/II study of recombinant human serum albumin-containing ophthalmic solution (development code: RU-101) in US. The two-stage trial is performed as a double masking test ...
Tags: R-Tech, Dry Eye Study